285 related articles for article (PubMed ID: 14550831)
21. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Katofiasc MA; Nissen J; Audia JE; Thor KB
Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
[TBL] [Abstract][Full Text] [Related]
22. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
Freeman RM
BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
Rueter LE; De Montigny C; Blier P
J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
[TBL] [Abstract][Full Text] [Related]
24. [New options in pharmacological treatment of urinary stress incontinence in women].
Martan A
Ceska Gynekol; 2004 Nov; 69(6):500-6. PubMed ID: 15633423
[TBL] [Abstract][Full Text] [Related]
25. The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.
Mehnert U; Boy S; Widmer-Simitovic S; Reitz A; Schurch B
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Jun; 20(6):659-66. PubMed ID: 19271093
[TBL] [Abstract][Full Text] [Related]
26. [Pharmaceutical treatment of stress incontinence. New approaches via a direct effect of duloxetine on Onuf's nucleus].
Jost WH; Marsalek P; Manning M; Jünemann KP
Urologe A; 2004 Oct; 43(10):1249-53. PubMed ID: 15322758
[TBL] [Abstract][Full Text] [Related]
27. Neurophysiology and therapeutic receptor targets for stress urinary incontinence.
Yoshimura N; Miyazato M
Int J Urol; 2012 Jun; 19(6):524-37. PubMed ID: 22404481
[TBL] [Abstract][Full Text] [Related]
28. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
Alberti C
G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
[TBL] [Abstract][Full Text] [Related]
29. Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.
Kitta T; Miyazato M; Chancellor MB; de Groat WC; Nonomura K; Yoshimura N
J Urol; 2010 Aug; 184(2):762-8. PubMed ID: 20639053
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine in the treatment of stress urinary incontinence.
Jost WH; Marsalek P
Ther Clin Risk Manag; 2005 Dec; 1(4):259-64. PubMed ID: 18360568
[TBL] [Abstract][Full Text] [Related]
31. [Place of duloxetine in the treatment of stress urinary incontinence].
Rouprêt M; Richard F; Chartier-Kastler E
Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
[TBL] [Abstract][Full Text] [Related]
32. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
33. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine for management of stress urinary incontinence.
Guay DR
Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
[TBL] [Abstract][Full Text] [Related]
35. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic treatment of stress urinary incontinence: expectations for outcome.
Schuessler B; Baessler K
Urology; 2003 Oct; 62(4 Suppl 1):31-8. PubMed ID: 14550835
[TBL] [Abstract][Full Text] [Related]
37. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
[TBL] [Abstract][Full Text] [Related]
38. Effects of Duloxetine on Urethral Continence Reflex and Bladder Activity in Rats with Cerebral Infarction.
Miyazato M; Kitta T; Kaiho Y; Oshiro T; Saito S; Chancellor MB; de Groat WC; Yoshimura N
J Urol; 2015 Sep; 194(3):842-7. PubMed ID: 25804088
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine in women awaiting surgery.
Drutz H
BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
[TBL] [Abstract][Full Text] [Related]
40. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
Thor KB; Kirby M; Viktrup L
Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
